Evidence map›Paper›PMID 12452845›Full record

ArticleClinical and experimental immunology2002

Selective reduction of intestinal trefoil factor in untreated coeliac disease.

C Ciacci, D Di Vizio, R Seth, G Insabato, G Mazzacca, D K Podolsky, Y R Mahida

Open access · greenAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Targeting Hypoxia to Augment Mucosal Barrier Function.Journal of epithelial biology & pharmacology · 2012
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

C CiacciDivision of Gastroenterology and Division of Pathology, Federico II University, Napoli, Italy.
D Di Vizio
R Seth
G Insabato
G Mazzacca
D K Podolsky
Y R Mahida
Federico II University Hospital · ITQueen's Medical Centre · GBUniversity of Naples Federico II · ITMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The trefoil factor family (TFF) encompasses small peptides of which intestinal trefoil factor (ITF) is expressed specifically in goblet cells of the small and large intestine. Previous studies have shown that ITF plays an important role in mucosal protection and repair. Coeliac disease represents a model of immune-mediated small intestinal inflammation and damage, with recovery on gluten-free diet. The aim of this study was to investigate the expression of ITF in the distal duodenal mucosa of subjects with coeliac disease, before and after treatment with a gluten-free diet. Expression of ITF and mucin in the distal duodenal biopsies from treated (n = 11) and untreated (n = 9) coeliac subjects and controls (n = 8) was investigated by immunohistochemistry and semiquantitative PCR. In untreated coeliac disease, there was reduction of ITF immunoreactivity in goblet cells but mucin expression was preserved. Mucosal recovery on gluten-free diet was associated with increased ITF immunoreactivity in goblet cells. There was also reduction in the expression of ITF transcripts, relative to MUC2 mRNA, in untreated coeliac duodenal samples, with recovery on gluten-free diet. Our study suggests that there is a selective reduction in the expression of the ITF gene in untreated coeliac disease. Recovery of ITF expression on a gluten-free diet suggests that the mucosal immune system regulates goblet cell differentiation and ITF expression in the human intestinal mucosa.

Indexed as

MucinsMuscle ProteinsNeuropeptidesRepressor ProteinsTranscription FactorsAdultBacterial ProteinsCase-Control StudiesCeliac DiseaseDuodenumFemaleGoblet CellsGrowth SubstancesHumansIntestinal MucosaMaleBacterial ProteinsGrowth SubstancesMucinsMucR protein, Rhizobium melilotiMuscle ProteinsNeuropeptidesPeptidesRepressor ProteinsRNA, MessengerTFF3 protein, ratTranscription FactorsTrefoil Factor-2Trefoil Factor-3

Identifiers

PMID12452845
PMCPMC1906543
OpenAlexW1991326086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.